Humana
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Humana in real time with a live news feed covering Humana stock news, official press releases, company announcements, and an archive of historical Humana news. ...more
Loading news...
Loading more...
12:29 PM | Thursday | Nov 12, 2026
Sign in to download news snippet
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full articleNo data available for this time period.
Change the time range to see results.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced that it has commenced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 9, 2026 (the “Offer to Purchase”). The Notes offered to be purchased in the Offers, in the order of acceptance priority, are the 2.150% Senior Notes due 2032; 3.
125% Sen.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share for the quarter ended September 30, 2026 (3Q26) versus the quarter ended September 30, 2025 (3Q25) and for the nine months ended September 30, 2026 (YTD 2026) versus the nine months ended September 30, 2025 (YTD 2025) as noted in the tables below. Consolidated income (loss) before income taxes and equity in net losses (pretax results) In millions 3Q26 (a) 3Q25 (a).
Read full article
BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and athenahealth today announced an expansion of electronic prior authorization capabilities across athenahealth's nationwide network of more than 180,000 physicians and clinicians, bringing more of the process directly into the tools they already use. The collaboration supports Humana's broader strategy to help patients access care more quickly by requiring prior authorization less often and making it simpler, faster and more connected when it.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 29, 2027 to stockholders of record as of the close of business on December 24, 2026. About Humana Humana (NYSE: HUM) is a leading U.
S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best heal.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (“BlackRock”), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will rep.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare and Medicaid Services (CMS). Additionally, 42% of Humana Medicare Advantage members are enrolled in 4.
5-star plans for 2027.“We're extremely proud of these Star Ratings. Th.
SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana Inc. (NYSE: HUM) following a court ruling that key claims in a securities fraud lawsuit against Humana and its former CEO and CFO will move forward. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.
com/humana.
SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that Humana will provide coverage for implantable tibial neuromodulation therapy for the treatment of UUI, including the Revi System, effective October 1, 2026.Humana is the second-largest Medicare Advantage organization in the U.S., with approximately 11 million enrollees in.
Read full article
No data available for this time period.
Change the time range to see results.